SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Petra Mlcochova,
Steven A Kemp,
Mahesh Shanker Dhar,
Guido Papa,
Bo Meng,
Isabella ATM Ferreira,
Rawlings Datir,
Dami A Collier,
Anna Albecka,
Sujeet Singh,
Rajesh Pandey,
Jonathan Brown,
Jie Zhou,
Niluka Goonawardane,
Swapnil Mishra,
Charles Whittaker,
Thomas Mellan,
Robin Marwal,
Meena Datta,
Shantanu Sengupta,
Kalaiarasan Ponnusamy,
Venkatraman Srinivasan Radhakrishnan,
Adam Abdullahi,
Oscar Charles,
Partha Chattopadhyay,
Priti Devi,
Daniela Caputo,
Tom Peacock,
Chand Wattal,
Neeraj Goel,
Ambrish Satwik,
Raju Vaishya,
Meenakshi Agarwal,
Indian SARS-CoV-2 Genomics Consortium (INSACOG),
Genotype to Phenotype Japan (G2P-Japan) Consortium,
CITIID-NIHR BioResource COVID-19 Collaboration,
Antranik Mavousian,
Joo Hyeon Lee,
Jessica Bassi,
Chiara Silacci-Fegni,
Christian Saliba,
Dora Pinto,
Takashi Irie,
Isao Yoshida,
William L Hamilton,
Kei Sato,
Samir Bhatt,
Seth Flaxman,
Leo C James,
Davide Corti,
Luca Piccoli,
Wendy S Barclay,
Partha Rakshit,
Anurag Agrawal,
Ravindra K Gupta
Sep 10, 2021
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages...